Archivo de etiqueta: Diagnostic Cytopathology

Risk of HSIL (CIN 2–3) on colposcopic biopsy is minimal in postmenopausal women with LSIL on cytology and a negative HRHPV test.

Abstract. Background: Current cervical cancer screening guidelines recommend a 1-year follow-up period for patients with a postmenopausal low-grade squamous intraepithelial lesion (LSIL) who are test negative for high-risk human papillomavirus (HrHPV). The aim of this study was to assess whether such patients had an increased immediate risk of high-grade squamous intraepithelial lesion. Methods: We assessedSigueSigue leyendo «Risk of HSIL (CIN 2–3) on colposcopic biopsy is minimal in postmenopausal women with LSIL on cytology and a negative HRHPV test.»

Management of ASC-US or LSIL of the uterine cervix with human papilloma virus infection among young women aged less than 25 years.

Abstract.Current ASCCP guidelines recommend repeat cytology 12 months after HPV-positive results in women aged 21–24 years with either atypical squamous cells of undetermined significance (ASCUS) or a low-grade squamous intraepithelial lesion (LSIL). The purpose of this study was to validate an algorithm in such women with ASCUS or LSIL. A multicenter cross-sectional study was carriedSigueSigue leyendo «Management of ASC-US or LSIL of the uterine cervix with human papilloma virus infection among young women aged less than 25 years.»